Analyst Ratings for Nautilus Biotechnology (NAUT)
NAUT Rating Summary
NAUT Price Target Summary
- Highest: $4.00 (Guggenheim)
- Lowest: $3.50 (Roth/MKM)
- Average: $3.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$3.83 (+86.1%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$3.83 (+86.1%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2026 | Roth/MKM | Max Masucci | New Coverage | Buy (N/A) |
3.50 (N/A) |
0.96 (2.06) |
114.58% | Details |
| 9/9/2026 | Leerink | Daniel Clark | New Coverage | Outperform (N/A) |
4.00 (N/A) |
0.93 (2.06) |
121.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
